APA
Witt M., Grunke M., Proft F., Baeuerle M., Aringer M., Burmester G., Chehab G., Fiehn C., Fischer-Betz R., Fleck M., Freivogel K., Haubitz M., Kötter I., Lovric S., Metzler C., Rubberth-Roth A., Schwarting A., Specker C., Tony H., Unger L., Wassenberg S., Dörner T. & Schulze-Koops H. (20140530). Clinical outcomes and safety of rituximab treatment for patients with systemic lupus erythematosus (SLE) - results from a nationwide cohort in Germany (GRAID). : Lupus.
Chicago
Witt M, Grunke M, Proft F, Baeuerle M, Aringer M, Burmester G, Chehab G, Fiehn C, Fischer-Betz R, Fleck M, Freivogel K, Haubitz M, Kötter I, Lovric S, Metzler C, Rubberth-Roth A, Schwarting A, Specker C, Tony H-P, Unger L, Wassenberg S, Dörner T and Schulze-Koops H. 20140530. Clinical outcomes and safety of rituximab treatment for patients with systemic lupus erythematosus (SLE) - results from a nationwide cohort in Germany (GRAID). : Lupus.
Harvard
Witt M., Grunke M., Proft F., Baeuerle M., Aringer M., Burmester G., Chehab G., Fiehn C., Fischer-Betz R., Fleck M., Freivogel K., Haubitz M., Kötter I., Lovric S., Metzler C., Rubberth-Roth A., Schwarting A., Specker C., Tony H., Unger L., Wassenberg S., Dörner T. and Schulze-Koops H. (20140530). Clinical outcomes and safety of rituximab treatment for patients with systemic lupus erythematosus (SLE) - results from a nationwide cohort in Germany (GRAID). : Lupus.
MLA
Witt M, Grunke M, Proft F, Baeuerle M, Aringer M, Burmester G, Chehab G, Fiehn C, Fischer-Betz R, Fleck M, Freivogel K, Haubitz M, Kötter I, Lovric S, Metzler C, Rubberth-Roth A, Schwarting A, Specker C, Tony H-P, Unger L, Wassenberg S, Dörner T and Schulze-Koops H. Clinical outcomes and safety of rituximab treatment for patients with systemic lupus erythematosus (SLE) - results from a nationwide cohort in Germany (GRAID). : Lupus. 20140530.